Joelle N. Pelletier, Ph.D. - Publications

Affiliations: 
Université de Montréal, Montréal, Canada 

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lemay-St-Denis C, Pelletier JN. From a binding module to essential catalytic activity: how nature stumbled on a good thing. Chemical Communications (Cambridge, England). 59: 12560-12572. PMID 37791701 DOI: 10.1039/d3cc04209j  0.318
2023 Lemay-St-Denis C, Alejaldre L, Jemouai Z, Lafontaine K, St-Aubin M, Hitache K, Valikhani D, Weerasinghe NW, Létourneau M, Thibodeaux CJ, Doucet N, Baron C, Copp JN, Pelletier JN. A conserved SH3-like fold in diverse putative proteins tetramerizes into an oxidoreductase providing an antimicrobial resistance phenotype. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 378: 20220040. PMID 36633286 DOI: 10.1098/rstb.2022.0040  0.646
2022 Lemay-St-Denis C, Doucet N, Pelletier JN. Integrating dynamics into enzyme engineering. Protein Engineering, Design & Selection : Peds. PMID 36416215 DOI: 10.1093/protein/gzac015  0.629
2020 Deweid L, Hadjabdelhafid-Parisien A, Lafontaine K, Rochet LNC, Kolmar H, Pelletier JN. Glutamine-walking: Creating reactive substrates for transglutaminase-mediated protein labeling. Methods in Enzymology. 644: 121-148. PMID 32943142 DOI: 10.1016/Bs.Mie.2020.04.066  0.364
2019 Gobeil SMC, Ebert MCCJC, Park J, Gagné D, Doucet N, Berghuis AM, Pleiss J, Pelletier JN. The Structural Dynamics of Engineered β-Lactamases Vary Broadly on Three Timescales yet Sustain Native Function. Scientific Reports. 9: 6656. PMID 31040324 DOI: 10.1038/S41598-019-42866-8  0.759
2019 Quaglia D, Alejaldre L, Ouadhi S, Rousseau O, Pelletier JN. Holistic engineering of Cal-A lipase chain-length selectivity identifies triglyceride binding hot-spot. Plos One. 14: e0210100. PMID 30640952 DOI: 10.1371/Journal.Pone.0210100  0.383
2017 Charbonneau DM, Aubé A, Rachel NM, Guerrero V, Delorme K, Breault-Turcot J, Masson JF, Pelletier JN. Development of Asparaginase II for Immunosensing: A Trade-Off between Receptor Density and Sensing Efficiency. Acs Omega. 2: 2114-2125. PMID 30023654 DOI: 10.1021/acsomega.7b00110  0.648
2017 Charbonneau DM, Breault-Turcot J, Sinnett D, Krajinovic M, Leclerc JM, Masson JF, Pelletier JN. Tracking silent hypersensitivity reactions to asparaginase during leukemia therapy using single-chip indirect plasmonic and fluorescence immunosensing. Acs Sensors. PMID 29168384 DOI: 10.1021/Acssensors.7B00584  0.66
2017 Rachel NM, Toulouse JL, Pelletier JN. Transglutaminase-Catalyzed Bioconjugation Using One-Pot Metal-Free Bioorthogonal Chemistry. Bioconjugate Chemistry. PMID 28898047 DOI: 10.1021/Acs.Bioconjchem.7B00509  0.339
2017 Rachel NM, Quaglia D, Lévesque É, Charette AB, Pelletier JN. Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements. Protein Science : a Publication of the Protein Society. PMID 28857311 DOI: 10.1002/Pro.3286  0.417
2017 Ebert MC, Pelletier JN. Computational tools for enzyme improvement: why everyone can - and should - use them. Current Opinion in Chemical Biology. 37: 89-96. PMID 28231515 DOI: 10.1016/J.Cbpa.2017.01.021  0.34
2017 Quaglia D, Ebert MC, Mugford PF, Pelletier JN. Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening. Plos One. 12: e0171741. PMID 28178357 DOI: 10.1371/Journal.Pone.0171741  0.357
2017 Ebert MCCJC, Guzman Espinola J, Lamoureux G, Pelletier JN. Substrate-Specific Screening for Mutational Hotspots Using Biased Molecular Dynamics Simulations Acs Catalysis. 7: 6786-6797. DOI: 10.1021/Acscatal.7B02634  0.348
2016 Aubé A, Charbonneau DM, Pelletier JN, Masson J. Response Monitoring of Acute Lymphoblastic Leukemia Patients Undergoing l-Asparaginase Therapy: Successes and Challenges Associated with Clinical Sample Analysis in Plasmonic Sensing Acs Sensors. 1: 1358-1365. DOI: 10.1021/Acssensors.6B00531  0.654
2016 St-Jacques AD, Rachel NM, Curry DR, Gillet SMFG, Clouthier CM, Keillor JW, Pelletier JN, Chica RA. Specificity of transglutaminase-catalyzed peptide synthesis Journal of Molecular Catalysis B: Enzymatic. 123: 53-61. DOI: 10.1016/J.Molcatb.2015.11.009  0.677
2015 Gobeil SM, Gagné D, Doucet N, Pelletier JN. (15)N, (13)C and (1)H backbone resonance assignments of an artificially engineered TEM-1/PSE-4 class A β-lactamase chimera and its deconvoluted mutant. Biomolecular Nmr Assignments. PMID 26386961 DOI: 10.1007/S12104-015-9645-8  0.755
2015 Ebert MC, Morley KL, Volpato JP, Schmitzer AR, Pelletier JN. Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active-site substitutions. Protein Science : a Publication of the Protein Society. 24: 495-507. PMID 25401264 DOI: 10.1002/Pro.2602  0.374
2015 Gobeil SMC, Gagne D, Doucet N, Pelletier JN. 15N, 13C and 1H backbone resonance assignments of TEM-1(M68L-M69T) Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr26586  0.731
2014 Gobeil SM, Clouthier CM, Park J, Gagné D, Berghuis AM, Doucet N, Pelletier JN. Maintenance of native-like protein dynamics may not be required for engineering functional proteins. Chemistry & Biology. 21: 1330-40. PMID 25200606 DOI: 10.1016/J.Chembiol.2014.07.016  0.762
2014 Bukar N, Zhao SS, Charbonneau DM, Pelletier JN, Masson JF. Influence of the Debye length on the interaction of a small molecule-modified Au nanoparticle with a surface-bound bioreceptor. Chemical Communications (Cambridge, England). 50: 4947-50. PMID 24705454 DOI: 10.1039/C4Cc01423E  0.645
2014 Gundersen MT, Keillor JW, Pelletier JN. Microbial transglutaminase displays broad acyl-acceptor substrate specificity Applied Microbiology and Biotechnology. 98: 219-230. PMID 23615739 DOI: 10.1007/S00253-013-4886-X  0.354
2012 Clouthier CM, Morin S, Gobeil SM, Doucet N, Blanchet J, Nguyen E, Gagné SM, Pelletier JN. Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions. Plos One. 7: e52283. PMID 23284969 DOI: 10.1371/Journal.Pone.0052283  0.762
2012 Zhao SS, Bichelberger MA, Colin DY, Robitaille R, Pelletier JN, Masson JF. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor. The Analyst. 137: 4742-50. PMID 22943049 DOI: 10.1039/C2An35839E  0.313
2012 Gnaccarini C, Ben-Tahar W, Mulani A, Roy I, Lubell WD, Pelletier JN, Keillor JW. Site-specific protein propargylation using tissue transglutaminase. Organic & Biomolecular Chemistry. 10: 5258-65. PMID 22653499 DOI: 10.1039/C2Ob25752A  0.378
2012 Zhao SS, Bolduc OR, Colin DY, Pelletier JN, Masson JF. Development of LSPR and SPR sensor for the detection of an anti-cancer drug for chemotherapy Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8234. DOI: 10.1117/12.909578  0.321
2011 Yachnin BJ, Colin DY, Volpato JP, Ebert M, Pelletier JN, Berghuis AM. Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure Acta Crystallographica Section F: Structural Biology and Crystallization Communications. 67: 1316-1322. PMID 22102224 DOI: 10.1107/S1744309111030417  0.311
2011 Tang MC, Nisole A, Dupont C, Pelletier JN, Waldron KC. Chemical profiling of the deacetylase activity of acetyl xylan esterase A (AxeA) variants on chitooligosaccharides using hydrophilic interaction chromatography-mass spectrometry Journal of Biotechnology. 155: 257-265. PMID 21767585 DOI: 10.1016/J.Jbiotec.2011.06.041  0.361
2011 Bolduc OR, Lambert-Lanteigne P, Colin DY, Zhao SS, Proulx C, Boeglin D, Lubell WD, Pelletier JN, Féthière J, Ong H, Masson JF. Modified peptide monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensors. The Analyst. 136: 3142-8. PMID 21698315 DOI: 10.1039/C1An15235A  0.324
2011 Doucet N, Pelletier JN. Gaining Insight into Enzyme Function through Correlation with Protein Motions Protein Engineering Handbook, Volume 1 & Volume 2. 1: 187-211. DOI: 10.1002/9783527634026.ch7  0.613
2010 Morin S, Clouthier CM, Gobeil S, Pelletier JN, Gagné SM. Backbone resonance assignments of an artificially engineered TEM-1/PSE-4 Class A β-lactamase chimera. Biomolecular Nmr Assignments. 4: 127-30. PMID 20383614 DOI: 10.1007/S12104-010-9227-8  0.673
2009 Gnaccarini C, Ben-Tahar W, Lubell WD, Pelletier JN, Keillor JW. Fluorometric assay for tissue transglutaminase-mediated transamidation activity Bioorganic and Medicinal Chemistry. 17: 6354-6359. PMID 19660958 DOI: 10.1016/J.Bmc.2009.07.031  0.335
2009 Volpato JP, Yachnin BJ, Blanchet J, Guerrero V, Poulin L, Fossati E, Berghuis AM, Pelletier JN. Multiple conformers in active site of human dihydrofolate reductase F31R/Q35E double mutant suggest structural basis for methotrexate resistance Journal of Biological Chemistry. 284: 20079-20089. PMID 19478082 DOI: 10.1074/Jbc.M109.018010  0.402
2009 Volpato JP, Pelletier JN. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: Sequence and structural comparison Drug Resistance Updates. 12: 28-41. PMID 19272832 DOI: 10.1016/J.Drup.2009.02.001  0.301
2009 Pardin C, Roy I, Chica RA, Bonneil E, Thibault P, Lubell WD, Pelletier JN, Keillor JW. Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors Biochemistry. 48: 3346-3353. PMID 19271761 DOI: 10.1021/Bi802021C  0.674
2009 De Wals PY, Doucet N, Pelletier JN. High tolerance to simultaneous active-site mutations in TEM-1 β-lactamase: Distinct mutational paths provide more generalized β-lactam recognition Protein Science. 18: 147-160. PMID 19177359 DOI: 10.1002/Pro.25  0.627
2008 Pardin C, Pelletier JN, Lubell WD, Keillor JW. Cinnamoyl inhibitors of tissue transglutaminase Journal of Organic Chemistry. 73: 5766-5775. PMID 18582115 DOI: 10.1021/Jo8004843  0.322
2008 Fossati E, Volpato JP, Poulin L, Guerrero V, Dugas DA, Pelletier JN. 2-Tier bacterial and in vitro selection of active and methotrexate- resistant variants of human dihydrofolate reductase Journal of Biomolecular Screening. 13: 504-514. PMID 18566481 DOI: 10.1177/1087057108318783  0.374
2008 Keillor JW, Chica RA, Chabot N, Vinci V, Pardin C, Fortin E, Gillet SMFG, Nakano Y, Kaartinen MT, Pelletier JN, Lubell WD. The bioorganic chemistry of transglutaminase - from mechanism to inhibition and engineering Canadian Journal of Chemistry. 86: 271-276. DOI: 10.1139/V08-024  0.682
2007 Volpato JP, Fossati E, Pelletier JN. Increasing Methotrexate Resistance by Combination of Active-site Mutations in Human Dihydrofolate Reductase Journal of Molecular Biology. 373: 599-611. PMID 17868689 DOI: 10.1016/J.Jmb.2007.07.076  0.312
2007 Doucet N, Pelletier JN. Simulated annealing exploration of an active-site tyrosine in TEM-1β-lactamase suggests the existence of alternate conformations Proteins: Structure, Function and Genetics. 69: 340-348. PMID 17600829 DOI: 10.1002/Prot.21485  0.655
2007 Doucet N, Savard PY, Pelletier JN, Gagné SM. NMR investigation of Tyr105 mutants in TEM-1 beta-lactamase: dynamics are correlated with function. The Journal of Biological Chemistry. 282: 21448-59. PMID 17426035 DOI: 10.1074/Jbc.M609777200  0.657
2007 Denault M, Pelletier JN. Protein library design and screening: working out the probabilities. Methods in Molecular Biology (Clifton, N.J.). 352: 127-154. PMID 17041263 DOI: 10.1385/1-59745-187-8:127  0.346
2005 Gillet SMFG, Pelletier JN, Keillor JW. A direct fluorometric assay for tissue transglutaminase Analytical Biochemistry. 347: 221-226. PMID 16289009 DOI: 10.1016/J.Ab.2005.09.035  0.309
2005 Chica RA, Doucet N, Pelletier JN. Semi-rational approaches to engineering enzyme activity: Combining the benefits of directed evolution and rational design Current Opinion in Biotechnology. 16: 378-384. PMID 15994074 DOI: 10.1016/J.Copbio.2005.06.004  0.767
2004 Schmitzer AR, Lépine F, Pelletier JN. Combinatorial exploration of the catalytic site of a drug-resistant dihydrofolate reductase: Creating alternative functional configurations Protein Engineering, Design and Selection. 17: 809-819. PMID 15576381 DOI: 10.1093/Protein/Gzh090  0.344
2004 Doucet N, De Wals PY, Pelletier JN. Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 β-lactamase Journal of Biological Chemistry. 279: 46295-46303. PMID 15326193 DOI: 10.1074/Jbc.M407606200  0.652
2004 Tousignant A, Pelletier JN. Protein motions promote catalysis Chemistry and Biology. 11: 1037-1042. PMID 15324804 DOI: 10.1016/J.Chembiol.2004.06.007  0.392
2004 Chica RA, Gagnon P, Keillor JW, Pelletier JN. Tissue transglutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding Protein Science. 13: 979-991. PMID 15010546 DOI: 10.1110/Ps.03433304  0.683
2004 Gillet SMFG, Chica RA, Keillor JW, Pelletier JN. Expression and rapid purification of highly active hexahistidine-tagged guinea pig liver transglutaminase Protein Expression and Purification. 33: 256-264. PMID 14711514 DOI: 10.1016/J.Pep.2003.10.003  0.675
2002 Arndt KM, Pelletier JN, Müller KM, Plückthun A, Alber T. Comparison of in vivo selection and rational design of heterodimeric coiled coils. Structure (London, England : 1993). 10: 1235-48. PMID 12220495 DOI: 10.1016/S0969-2126(02)00838-9  0.466
2002 Amstutz P, Pelletier JN, Guggisberg A, Jermutus L, Cesaro-Tadic S, Zahnd C, Plückthun A. In vitro selection for catalytic activity with ribosome display. Journal of the American Chemical Society. 124: 9396-403. PMID 12167034 DOI: 10.1021/Ja025870Q  0.504
2001 Pelletier J, Sidhu S. Mapping protein-protein interactions with combinatorial biology methods Current Opinion in Biotechnology. 12: 340-347. PMID 11551461 DOI: 10.1016/S0958-1669(00)00225-1  0.324
2000 Michnick SW, Remy I, Campbell-Valois FX, Vallée-Bélisle A, Pelletier JN. Detection of protein-protein interactions by protein fragment complementation strategies. Methods in Enzymology. 328: 208-30. PMID 11075347 DOI: 10.1016/S0076-6879(00)28399-7  0.77
2000 Arndt KM, Pelletier JN, Müller KM, Alber T, Michnick SW, Plückthun A. A heterodimeric coiled-coil peptide pair selected in vivo from a designed library-versus-library ensemble. Journal of Molecular Biology. 295: 627-39. PMID 10623552 DOI: 10.1006/Jmbi.1999.3352  0.659
1999 Pelletier JN, Arndt KM, Plückthun A, Michnick SW. An in vivo library-versus-library selection of optimized protein-protein interactions. Nature Biotechnology. 17: 683-90. PMID 10404162 DOI: 10.1038/10897  0.643
1998 Pelletier JN, Campbell-Valois FX, Michnick SW. Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proceedings of the National Academy of Sciences of the United States of America. 95: 12141-6. PMID 9770453 DOI: 10.1073/Pnas.95.21.12141  0.65
1997 Pelletier JN, Michnick SW. A protein complementation assay for detection of protein-protein interactions in vivo Protein Engineering. 10: 89.  0.55
1996 Allaire M, Li Y, Mejia NR, Pelletier JN, MacKenzie RE, Cygler M. Crystallization of the bifunctional methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase domain of the human trifunctional enzyme Proteins: Structure, Function and Genetics. 26: 479-480. PMID 8990501 DOI: 10.1002/(Sici)1097-0134(199612)26:4<479::Aid-Prot9>3.0.Co;2-6  0.587
1996 Pelletier JN, Mackenzie RE. Methenyltetrahydrofolate cyclohydrolase catalyzes the synthesis of (6S)-5-formyltetrahydrofolate Bioorganic Chemistry. 24: 220-228. DOI: 10.1006/Bioo.1996.0020  0.581
1995 Pelletier JN, MacKenzie RE. Binding and interconversion of tetrahydrofolates at a single site in the bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase Biochemistry. 34: 12673-12680. PMID 7548019 DOI: 10.1021/Bi00039A025  0.61
1994 Pelletier JN, MacKenzie RE. Binding to the 2′,5′-ADP subsite stimulates cyclohydrolase activity of human NADP+-dependent methylenetetrahydrofolate dehydrogenase/cyclohydrolase Biochemistry. 33: 1900-1906. PMID 8110794 DOI: 10.1021/Bi00173A037  0.621
Show low-probability matches.